
Intel to buy Israeli firm Granulate Cloud Solutions for $650m.
Granulate, a member of the first cohort of Intel Ignite in 2019, reportedly is being acquired for $650 million.

Granulate, a member of the first cohort of Intel Ignite in 2019, reportedly is being acquired for $650 million.

Buyout of Oribi will accelerate LinkedIn’s marketing attribution capabilities; a new LinkedIn office will be established in Israel.

Tower, based in northern Israel, is a foundry for analog semiconductors in global high-growth markets such as mobile, automotive and power.

‘People here are born to believe, to never give up. This mentality is what has made Israel a miracle in only 70 years,’ says Alibaba founder in IVC report.

As funding totals near $10b, investment insiders explain the successes — and challenges — that 2020 brought for blue-and-white companies.

Exits down, but for some companies growth continued during the Covid-19 crisis and specific sectors are flourishing.

Joining Intel and its Israeli subsidiary Mobileye, Moovit will advance Mobility-as-a-Service and the global adoption of autonomous transportation.

Mellanox and NVIDIA have a long history of collaboration, reflected in their joint contributions to building the world’s two fastest supercomputers.

The deal with Hellman & Friedman represents the largest acquisition of an application security company to date.

The Israel-founded, California-based cybersecurity firm specializes in device visibility and control for enterprises and government agencies.

In technology, digital health, tourism, exports and other verticals, Israel has seen steady growth through the past decade.

Largest-ever acquisition of a private Israeli cybersecurity company aims to better protect businesses against threats from connected devices.

The number of exit deals in 2019 was the highest in the past decade, and the average deal size was $124 million.

This is Intel’s second largest buyout in Israel, after its 2017 acquisition of Mobileye for $15.3 billion.

Baring Private Equity Asia to acquire Israeli maker of energy-based medical devices for aesthetics, urology, ophthalmology, ENT and gynecology.